the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
Biguanides has been studied across 18 research domains including 🔥 Metabolic, 🔬 Oncology, 🧬 Hormones, 🫁 Liver & Detox, ⚡ Energy & Fatigue. The primary research focus is 🔥 Metabolic with 62% of studies addressing this area.
This evidence profile for Biguanides is generated deterministically from 299 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.